AEON Biopharma, Inc. (AEON) NASDAQ
$0.77 0.03 (4.29%)
Market Cap: $30.50M
As of 09/13/24 11:02 AM EDT. Market open.
AEON Biopharma, Inc. (AEON)
NASDAQ
$0.77
0.03 (4.29%)
Market Cap: $30.50M
As of 09/13/24 11:02 AM EDT. Market open.
Add to Portfolio
AEON Biopharma, Inc., a biopharmaceutical company, focuses on the development botulinum toxins for the treatment of debilitating medical conditions. It also develops 900 kDabotulinum toxin complex, ABP-450, for migraine, cervical dystonia, and gastroparesis. The company was formerly known as ALPHAEON Corporation and changed its name to AEON Biopharma, Inc. in December 2019. AEON Biopharma, Inc. ... read more
COMPANY PROFILE
Sector
Healthcare
Industry
Biotechnology
CEO
Mr. Marc Forth
Full Time Employees
5
Sector
Healthcare
Industry
Biotechnology
CEO
Mr. Marc Forth
Full Time Employees
5
Address
4040 Macarthur Boulevard, CA, Newport Beach, 92614.
PRICE CHART FOR AEON BIOPHARMA, INC.
From:
To:
NEWS
INSIDEARBITRAGE ARTICLES
KEY STATS
Open
$0.74
Previous Close
$0.74
Days Range
$0.74 - $0.80
52 week range
$0.71 - $17.17
Volume
31,974
Avg. Volume (30 days)
1,753,174
Market Cap
$30.50M
Dividend Yield
-
P/E
(5.14)
Shares Outstanding
39,522,200
Open
$0.74
Previous Close
$0.74
Days Range
$0.74 - $0.80
52 week range
$0.71 - $17.17
Volume
31,974
Avg. Volume (30 days)
1,753,174
Market Cap
$30.50M
Dividend Yield
-
P/E
(5.14)
Shares Outstanding
39,522,200
FINANCIAL STATEMENTS FOR AEON BIOPHARMA, INC.
LOADING...
Open in: 
Open in:
INSIDER TRANSACTIONS FOR AEON BIOPHARMA, INC.
| Owner | Relationship | Date | Transaction | Cost | # Shares | Value($) | Total Shares | Form 4 |
| Strathspey Crown Holdings Group, LLC | 10% Owner | Aug 11, 2023 | Sale | $10.00 | 7,380,394 | 73,803,940 | 2,031,773 | Aug 14, 2023, 04:10 PM |
Buy
Sale
Option Exercise
| Owner | Relationship | Date | Value($) |
| Strathspey Crown Holdings Group, LLC | 10% Owner | 08/11/2023 | 73,803,940 |
FUNDS WITH A POSITION IN AEON BIOPHARMA, INC.
| Fund | # Shares Owned | % of Portfolio | % Change | Investing Style |
|---|---|---|---|---|
| BLACKROCK INC. | 272,317 | 0.00001% | 6.61% | Other |
| GEODE CAPITAL MANAGEMENT, LLC | 186,858 | 0.00002% | 4.04% | Other |
| DAVIDSON KEMPNER CAPITAL MANAGEMENT LP | 90,053 | 0.00194% | New | Event Driven |
| DUPONT CAPITAL MANAGEMENT CORP | 12,282 | 0.00112% | 409300% | Other |
CHANGE IN SHARES OUTSTANDING FOR AEON BIOPHARMA, INC.
STOCK BUYBACKS FOR AEON BIOPHARMA, INC.
Period of Report
Previous Period
% Change in Shares
10-K/10-Q Filings
Quarter
Load More
Period of Report: 12/31/2023
10-K/10-Q Filings: View
Previous Period
% Change in Shares
Quarter
09/30/2023
0%
1Q
09/30/2022
-73.24%
5Q
06/30/2022
-73.23%
6Q
03/31/2022
7.71%
7Q
12/31/2021
-70.57%
8Q
09/30/2021
7.71%
9Q
06/30/2021
7.71%
10Q
03/31/2021
69.47%
11Q
Load More
BUYBACK ANNOUNCEMENT(S) FOR AEON BIOPHARMA, INC.
LOADING...